FXR agonist 13
FXR agonist 13 is a selective, orally active, potent FXR agonist (EC50 = 0.097 μM) and has favorable hepatic microsomal metabolic stability. FXR agonist 13 exhibits moderate affinity for FXR-LBD upon direct binding (KD = 14.74 μM) . FXR agonist 13 displays good selectivity against related nuclear receptors, including LXRα/β, PPARα/γ/δ, PXR, and TGR5. FXR agonist 13 can be used for the study of metabolic-associated steatohepatitis (MASH) [1].
Product Specifications
Target
FXR
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease; Inflammation/Immunology
Smiles
O=C(C1=CC=C(C=C1)CN(C(C2=NN(C3=C2C=CC=C3Cl)CCC(F)(F)F)=O)CC4=CC(F)=CC=C4)O
Molecular Formula
C26H20ClF4N3O3
Molecular Weight
533.90
References & Citations
[1]Shi DY, et al. Discovery of novel potent indazole-based FXR agonists via scaffold hopping for MASH treatment. Eur J Med Chem. 2026 Jan 5;301:118203.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
18587141 1x 10^6 Cells / 1.0 mL
DQX1 CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details 